                         SEQUENCE LISTING

<110>  Translate Bio, Inc.
 
<120>  MESSENGER RNA VACCINES AND USES THEREOF

<130>  MRT-2021WO

<140>  PCT/US19/34474
<141>  2019-05-29

<150>  62/678,225
<151>  2018-05-30

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  140
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  chemically synthesized oligonucleotide

<400>  1
ggacagaucg ccuggagacg ccauccacgc uguuuugacc uccauagaag acaccgggac       60

cgauccagcc uccgcggccg ggaacggugc auuggaacgc ggauuccccg ugccaagagu      120

gacucaccgu ccuugacacg                                                  140


<210>  2
<211>  105
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  chemically synthesized oligonucleotide

<400>  2
cggguggcau cccugugacc ccuccccagu gccucuccug gcccuggaag uugccacucc       60

agugcccacc agccuugucc uaauaaaauu aaguugcauc aagcu                      105


<210>  3
<211>  105
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  chemically synthesized oligonucleotide

<400>  3
ggguggcauc ccugugaccc cuccccagug ccucuccugg cccuggaagu ugccacucca       60

gugcccacca gccuuguccu aauaaaauua aguugcauca aagcu                      105


